Breakthrough HIV Prevention: New Injection Offers 100% Protection Against Deadly Infection

Breakthrough HIV Prevention: New Injection Offers 100% Protection Against Deadly Infection

A groundbreaking clinical trial in South Africa and Uganda has demonstrated that a new pre-exposure prophylaxis (PrEP) drug, administered via a twice-yearly injection, provides total protection against HIV infection in young women. The trial, involving 5,000 participants, tested the efficacy of lenacapavir, a fusion capsid inhibitor, against two other daily PrEP pills, Truvada (F/TDF) and…

Read More